• Westlake Bio Unveils $320M Fund to Put Los Angeles on the Biotech Map

    9 monthes ago - By Xconomy

    Los Angeles has long been in San Francisco's shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital. The Los Angeles-based firm is led by managing directors Beth Seidenberg, a former general partner at venture capital firm Kleiner Perkins, and Sean Harper, the outgoing executive vice president of research and development at Amgen. Harper will start with Westlake in January after retiring from Amgen...
    Read more ...